共 115 条
Anti-inflammatory effects of luteolin: A review of in vitro, in vivo, and in silico studies
被引:491
作者:
Aziz, Nur
[1
]
Kim, Mi-Yeon
[2
]
Cho, Jae Youl
[1
]
机构:
[1] Sungkyunkwan Univ, Dept Genet Engn, Suwon 16419, South Korea
[2] Soongsil Univ, Sch Syst Biomed Sci, Seoul 06978, South Korea
基金:
新加坡国家研究基金会;
关键词:
Luteolin;
Flavonoid;
Inflammatory diseases;
Inflammatory signaling;
NF-KAPPA-B;
ACTIVATED PROTEIN-KINASES;
INFLAMMATORY RESPONSES;
RAW;
264.7;
LYCHNOPHORA TRICHOCARPHA;
FLAVONOID LUTEOLIN;
OXIDATIVE STRESS;
MOLECULAR-BASIS;
NITRIC-OXIDE;
ANTIOXIDANT;
D O I:
10.1016/j.jep.2018.05.019
中图分类号:
Q94 [植物学];
学科分类号:
071001 [植物学];
摘要:
Ethnopharmacological relevance: Luteolin (3', 4', 5,7-tetrahydroxyflavone) has been identified as commonly present in plants. Plants with a high luteolin content have been used ethnopharmacologically to treat inflammation-related symptoms. Both isolated luteolin and extracts from luteolin-rich plants have been studied using various models and exhibited anti-inflammatory activity. Aim of the review: This paper uses recent research findings with a broad range of study models to describe the anti-inflammatory activity of luteolin, particularly its mechanisms at the molecular level; provide guidance for future research; and evaluate the feasibility of developing luteolin into an anti-inflammatory drug. Materials and methods: We summarize reports about the anti-inflammatory activity of luteolin published since 2009, which we found in MEDLINE/PubMed, Scopus, Web of Knowledge, and Google Scholar. To acquire broad information, we extended our search to online FDA documents. Results: Luteolin is a flavonoid commonly found in medicinal plants and has strong anti-inflammatory activity in vitro and in vivo. Some of its derivatives, such as luteolin-7-O-glucoside, have also shown anti-inflammatory activity. The action mechanism of luteolin varies, but Src in the nuclear factor (NF)-kappa B pathway, MAPK in the activator protein (AP)- 1 pathway, and SOCS3 in the signal transducer and activator of transcription 3 (STAT3) pathway are its major target transcription factors. A clinical trial with a formulation containing luteolin showed excellent therapeutic effect against inflammation-associated diseases. Conclusion: In silico, in vitro, in vivo, and clinical studies strongly suggest that the major pharmacological mechanism of luteolin is its anti-inflammatory activity, which derives from its regulation of transcription factors such as STAT3, NF-kappa B, and AP-1. Much work remains to ensure the safety, quality, and efficacy of luteolin before it can be used to treat inflammation-related diseases in humans.
引用
收藏
页码:342 / 358
页数:17
相关论文

